{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Air pollution", "CHIMERE", "Interstitial lung disease", "Nitrogen dioxide", "Ozone", "Particulate matter", "Progression", "Scleroderma", "Severity", "Systemic sclerosis"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37291562", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "12"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "12"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "06", "Day": "08"}], "ELocationID": ["151", "10.1186/s12931-023-02463-w"], "Journal": {"ISSN": "1465-993X", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "08"}}, "Title": "Respiratory research", "ISOAbbreviation": "Respir Res"}, "ArticleTitle": "The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study.", "Pagination": {"StartPage": "151", "MedlinePgn": "151"}, "Abstract": {"AbstractText": ["To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD.", "We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5\u00a0\u00b5m in diameter (PM<sub>10</sub>, PM<sub>2.5</sub>), nitrogen dioxide (NO<sub>2</sub>), and ozone (O<sub>3</sub>) was assessed at the geolocalization coordinates of the patients' residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24\u00a0months.", "We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O<sub>3</sub> exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05-1.21; p value\u2009=\u20090.002). At 12 and 24\u00a0months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O<sub>3</sub> exposure was associated with progression at 24\u00a0months (adjusted OR: 1.10, 95% CI 1.02-1.19; p value\u2009=\u20090.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression.", "Our findings suggest that high levels of O<sub>3</sub> exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24\u00a0months."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pulmonology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}], "LastName": "Roeser", "ForeName": "Ana\u00efs", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pulmonology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}, {"Identifier": [], "Affiliation": "INSERM UMR1272 Hypoxie et poumon, Paris 13 - Universit\u00e9 Paris Nord, Bobigny, France."}], "LastName": "Sese", "ForeName": "Lucile", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology A, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Chassagnon", "ForeName": "Guillaume", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Chaigne", "ForeName": "Benjamin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Dunogue", "ForeName": "Bertrand", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}], "LastName": "Tran Ba", "ForeName": "St\u00e9phane", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}], "LastName": "Jebri", "ForeName": "Salma", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}], "LastName": "Brillet", "ForeName": "Pierre-Yves", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology A, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Revel", "ForeName": "Marie Pierre", "Initials": "MP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Aubourg", "ForeName": "Fr\u00e9d\u00e9rique", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Paris, France."}], "LastName": "Dhote", "ForeName": "Robin", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Paris, France."}], "LastName": "Caux", "ForeName": "Fr\u00e9d\u00e9ric", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "INSERM, Department of Allergic and Respiratory Disease, Montpellier University Hospital, Institute Desbrest of Epidemiology and Public Health, University of Montpellier, Montpellier, France."}], "LastName": "Annesi-Maesano", "ForeName": "Isabella", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, Assistance Publique-H\u00f4pitaux de Paris (APHP), Cochin Hospital, Paris, France."}], "LastName": "Mouthon", "ForeName": "Luc", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pulmonology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France."}, {"Identifier": [], "Affiliation": "INSERM UMR1272 Hypoxie et poumon, Paris 13 - Universit\u00e9 Paris Nord, Bobigny, France."}], "LastName": "Nunes", "ForeName": "Hilario", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pulmonology, Assistance Publique-H\u00f4pitaux de Paris (APHP), Avicenne Hospital, Bobigny, France. yurdagul.uzunhan@aphp.fr."}, {"Identifier": [], "Affiliation": "INSERM UMR1272 Hypoxie et poumon, Paris 13 - Universit\u00e9 Paris Nord, Bobigny, France. yurdagul.uzunhan@aphp.fr."}], "LastName": "Uzunhan", "ForeName": "Yurdag\u00fcl", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Respir Res", "NlmUniqueID": "101090633", "ISSNLinking": "1465-9921"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "0", "NameOfSubstance": "Particulate Matter"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollution"}, {"QualifierName": ["diagnosis", "epidemiology", "etiology"], "DescriptorName": "Lung Diseases, Interstitial"}, {"QualifierName": ["adverse effects", "analysis"], "DescriptorName": "Air Pollutants"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["analysis"], "DescriptorName": "Particulate Matter"}, {"QualifierName": ["diagnosis", "epidemiology", "complications"], "DescriptorName": "Scleroderma, Systemic"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Environmental Exposure"}], "CoiStatement": "None of the authors has any conflict of interest related to this work to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hoffmann-Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med. 2019;200(10):1258\u20131266. doi: 10.1164/rccm.201903-0486OC.", "ArticleIdList": ["10.1164/rccm.201903-0486OC", "31310156"]}, {"Citation": "Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis. 2007;66(7):940\u2013944. doi: 10.1136/ard.2006.066068.", "ArticleIdList": ["10.1136/ard.2006.066068", "PMC1955114", "17329309"]}, {"Citation": "Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Air\u00f3 P, Ananieva LP, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis. 2020;80(2):219\u2013227. doi: 10.1136/annrheumdis-2020-217455.", "ArticleIdList": ["10.1136/annrheumdis-2020-217455", "PMC7815627", "32988845"]}, {"Citation": "Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis. Am J Respir Crit Care Med. 2008;177(11):1248\u20131254. doi: 10.1164/rccm.200706-877OC.", "ArticleIdList": ["10.1164/rccm.200706-877OC", "18369202"]}, {"Citation": "Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, et al. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis. 2019;78(1):122\u2013130. doi: 10.1136/annrheumdis-2018-213708.", "ArticleIdList": ["10.1136/annrheumdis-2018-213708", "PMC6311344", "30409830"]}, {"Citation": "Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69(8):1670\u20131678. doi: 10.1002/art.40130.", "ArticleIdList": ["10.1002/art.40130", "28426895"]}, {"Citation": "Winstone TA, Hague CJ, Soon J, Sulaiman N, Murphy D, Leipsic J, et al. Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease. Respirology. 2018;23(10):921\u2013926. doi: 10.1111/resp.13309.", "ArticleIdList": ["10.1111/resp.13309", "29641847"]}, {"Citation": "Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African-American race and antibodies to topoisomerase i are associated with increased severity of scleroderma lung disease. Chest. 1998;114(3):801\u2013807. doi: 10.1378/chest.114.3.801.", "ArticleIdList": ["10.1378/chest.114.3.801", "9743170"]}, {"Citation": "Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich \u00c9, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 2002;81(2):154\u2013167. doi: 10.1097/00005792-200203000-00005.", "ArticleIdList": ["10.1097/00005792-200203000-00005", "11889414"]}, {"Citation": "Conti S, Harari S, Caminati A, Zanobetti A, Schwartz JD, Bertazzi PA, et al. The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy. Eur Respir J. 2018;51(1):1700397. doi: 10.1183/13993003.00397-2017.", "ArticleIdList": ["10.1183/13993003.00397-2017", "29371377"]}, {"Citation": "Shull JG, Pay MT, Lara Compte C, Olid M, Bermudo G, Portillo K, et al. Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers. Respirology. 2021;26(4):352\u2013359. doi: 10.1111/resp.13973.", "ArticleIdList": ["10.1111/resp.13973", "33167075"]}, {"Citation": "Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, et al. Air pollution exposure is associated with lower lung function, but not changes in lung function, in patients with idiopathic pulmonary fibrosis. Chest. 2018;154(1):119\u2013125. doi: 10.1016/j.chest.2018.01.015.", "ArticleIdList": ["10.1016/j.chest.2018.01.015", "PMC6045778", "29355549"]}, {"Citation": "Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014;43(4):1124\u20131131. doi: 10.1183/09031936.00122213.", "ArticleIdList": ["10.1183/09031936.00122213", "PMC5555605", "24176998"]}, {"Citation": "Ses\u00e9 L, Nunes H, Cottin V, Sanyal S, Didier M, Carton Z, et al. Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis. Thorax. 2018;73(2):145\u2013150. doi: 10.1136/thoraxjnl-2017-209967.", "ArticleIdList": ["10.1136/thoraxjnl-2017-209967", "28798214"]}, {"Citation": "Dales R, Blanco-Vidal C, Cakmak S. The association between air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Chile: a daily time series analysis. Chest. 2020;158(2):630\u2013636. doi: 10.1016/j.chest.2020.02.017.", "ArticleIdList": ["10.1016/j.chest.2020.02.017", "32092324"]}, {"Citation": "Tahara M, Fujino Y, Yamasaki K, Oda K, Kido T, Sakamoto N, et al. Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case\u2013control study. Respir Res. 2021;22(1):80. doi: 10.1186/s12931-021-01671-6.", "ArticleIdList": ["10.1186/s12931-021-01671-6", "PMC7955640", "33711988"]}, {"Citation": "Winterbottom CJ, Shah RJ, Patterson KC, Kreider ME, Panettieri RA, Rivera-Lebron B, et al. Exposure to ambient particulate matter is associated with accelerated functional decline in idiopathic pulmonary fibrosis. Chest. 2018;153(5):1221\u20131228. doi: 10.1016/j.chest.2017.07.034.", "ArticleIdList": ["10.1016/j.chest.2017.07.034", "PMC6026290", "28802694"]}, {"Citation": "Yoon HY, Kim SY, Kim OJ, Song JW. Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis. Eur Respir J. 2021;57(5):2001877. doi: 10.1183/13993003.01877-2020.", "ArticleIdList": ["10.1183/13993003.01877-2020", "33184121"]}, {"Citation": "Aguilar PM, Carrera LG, Segura CC, S\u00e1nchez MIT, Pe\u00f1a MFV, Hern\u00e1n GB, et al. Relationship between air pollution levels in Madrid and the natural history of idiopathic pulmonary fibrosis: severity and mortality. J Int Med Res. 2021;49(7):3000605211029058. doi: 10.1177/03000605211029058.", "ArticleIdList": ["10.1177/03000605211029058", "PMC8278466", "34251275"]}, {"Citation": "Silman AJ, Howard Y, Hicklin AJ, Black C. Geographical clustering of scleroderma in South and West London. Rheumatology (Oxford) 1990;29(2):92\u201396. doi: 10.1093/rheumatology/29.2.92.", "ArticleIdList": ["10.1093/rheumatology/29.2.92", "2322780"]}, {"Citation": "Borghini A, Poscia A, Bosello S, Teleman AA, Bocci M, Iodice L, et al. Environmental pollution by benzene and PM10 and clinical manifestations of systemic sclerosis: a correlation study. Int J Environ Res Public Health. 2017;14(11):1297. doi: 10.3390/ijerph14111297.", "ArticleIdList": ["10.3390/ijerph14111297", "PMC5707936", "29072596"]}, {"Citation": "van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u20132747. doi: 10.1002/art.38098.", "ArticleIdList": ["10.1002/art.38098", "PMC3930146", "24122180"]}, {"Citation": "Akira M, Inoue Y, Arai T, Okuma T, Kawata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax. 2011;66(1):61\u201365. doi: 10.1136/thx.2010.140574.", "ArticleIdList": ["10.1136/thx.2010.140574", "21071764"]}, {"Citation": "Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u2013e68. doi: 10.1164/rccm.201807-1255ST.", "ArticleIdList": ["10.1164/rccm.201807-1255ST", "30168753"]}, {"Citation": "Silva CIS, M\u00fcller NL, Hansell DM, Lee KS, Nicholson AG, Wells AU. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology. 2008;247(1):251\u2013259. doi: 10.1148/radiol.2471070369.", "ArticleIdList": ["10.1148/radiol.2471070369", "18270375"]}, {"Citation": "Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u2013748. doi: 10.1164/rccm.201308-1483ST.", "ArticleIdList": ["10.1164/rccm.201308-1483ST", "PMC5803655", "24032382"]}, {"Citation": "Menut L, Bessagnet B, Khvorostyanov D, Beekmann M, Blond N, Colette A, et al. CHIMERE 2013: a model for regional atmospheric composition modelling. Geosci Model Dev. 2013;6(4):981\u20131028. doi: 10.5194/gmd-6-981-2013.", "ArticleIdList": ["10.5194/gmd-6-981-2013"]}, {"Citation": "Khanna D, Mittoo S, Aggarwal R, Proudman SM, Dalbeth N, Matteson EL, et al. Connective tissue disease-associated interstitial lung diseases (CTD-ILD)\u2014report from OMERACT CTD-ILD working group. J Rheumatol. 2015;42(11):2168\u20132171. doi: 10.3899/jrheum.141182.", "ArticleIdList": ["10.3899/jrheum.141182", "PMC4809413", "25729034"]}, {"Citation": "Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347. doi: 10.1164/rccm.202202-0399ST.", "ArticleIdList": ["10.1164/rccm.202202-0399ST", "PMC9851481", "35486072"]}, {"Citation": "Platenburg MGJP, van der Vis JJ, Kazemier KM, Grutters JC, van Moorsel CHM. The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD. Respir Med. 2022;194:106760. doi: 10.1016/j.rmed.2022.106760.", "ArticleIdList": ["10.1016/j.rmed.2022.106760", "35149406"]}, {"Citation": "Ambient (outdoor) air pollution. https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health. Accessed 1 Mar 2022."}, {"Citation": "Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000;21(1):1\u201348. doi: 10.1016/S0098-2997(00)00003-0.", "ArticleIdList": ["10.1016/S0098-2997(00)00003-0", "10804262"]}, {"Citation": "Jerrett M, Burnett RT, Pope CA, Ito K, Thurston G, Krewski D, et al. Long-term ozone exposure and mortality. N Engl J Med. 2009;360(11):1085\u20131095. doi: 10.1056/NEJMoa0803894.", "ArticleIdList": ["10.1056/NEJMoa0803894", "PMC4105969", "19279340"]}, {"Citation": "Ware LB, Zhao Z, Koyama T, May AK, Matthay MA, Lurmann FW, et al. Long-term ozone exposure increases the risk of developing the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2016;193(10):1143\u20131150. doi: 10.1164/rccm.201507-1418OC.", "ArticleIdList": ["10.1164/rccm.201507-1418OC", "PMC4872663", "26681363"]}, {"Citation": "Rush B, McDermid RC, Celi LA, Walley KR, Russell JA, Boyd JH. Association between chronic exposure to air pollution and mortality in the acute respiratory distress syndrome. Environ Pollut. 2017;224:352\u2013356. doi: 10.1016/j.envpol.2017.02.014.", "ArticleIdList": ["10.1016/j.envpol.2017.02.014", "PMC5683074", "28202265"]}, {"Citation": "Stockstill BL, Chang LY, M\u00e9nache MG, Mellick PW, Mercer RR, Crapo JD. Bronchiolarized metaplasia and interstitial fibrosis in rat lungs chronically exposed to high ambient levels of ozone. Toxicol Appl Pharmacol. 1995;134(2):251\u2013263. doi: 10.1006/taap.1995.1191.", "ArticleIdList": ["10.1006/taap.1995.1191", "7570602"]}, {"Citation": "Sherwin RP. Air pollution: the pathobiologic issues. J Toxicol Clin Toxicol. 1991;29(3):385\u2013400. doi: 10.3109/15563659109000365.", "ArticleIdList": ["10.3109/15563659109000365", "1920572"]}, {"Citation": "US EPA National Center for Environmental Assessment RTPN, Luben T. Integrated science assessment (ISA) for ozone and related photochemical oxidants (final report, Apr 2020). https://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=348522. Accessed 27 Feb 2022."}, {"Citation": "Tomos I, Dimakopoulou K, Manali ED, Papiris SA, Karakatsani A. Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis. Environ Health. 2021;20(1):99. doi: 10.1186/s12940-021-00786-z.", "ArticleIdList": ["10.1186/s12940-021-00786-z", "PMC8406600", "34461906"]}, {"Citation": "Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183\u20133194. doi: 10.1172/JCI28756.", "ArticleIdList": ["10.1172/JCI28756", "PMC1678820", "17143328"]}, {"Citation": "Hiramatsu K, Azuma A, Kudoh S, Desaki M, Takizawa H, Sugawara I. Inhalation of diesel exhaust for three months affects major cytokine expression and induces bronchus-associated lymphoid tissue formation in murine lungs. Exp Lung Res. 2003;29(8):607\u2013622. doi: 10.1080/01902140390240140.", "ArticleIdList": ["10.1080/01902140390240140", "14594659"]}, {"Citation": "Pabst R, Miller LA, Schelegle E, Hyde DM. Organized lymphatic tissue (BALT) in lungs of rhesus monkeys after air pollutant exposure. Anat Rec (Hoboken) 2020;303(11):2766\u20132773. doi: 10.1002/ar.24456.", "ArticleIdList": ["10.1002/ar.24456", "PMC8793891", "32445535"]}, {"Citation": "Dziedzic D, Wright ES, Sargent NE. Pulmonary response to ozone: reaction of bronchus-associated lymphoid tissue and lymph node lymphocytes in the rat. Environ Res. 1990;51(2):194\u2013208. doi: 10.1016/S0013-9351(05)80089-1.", "ArticleIdList": ["10.1016/S0013-9351(05)80089-1", "2335160"]}, {"Citation": "Chen C, Arjomandi M, Balmes J, Tager I, Holland N. Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ Health Perspect. 2007;115(12):1732\u20131737. doi: 10.1289/ehp.10294.", "ArticleIdList": ["10.1289/ehp.10294", "PMC2137098", "18087591"]}, {"Citation": "Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, et al. Reactive oxygen and nitrogen intermediates increase transforming growth factor-\u03b2 1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol. 1999;21(1):128\u2013136. doi: 10.1165/ajrcmb.21.1.3379.", "ArticleIdList": ["10.1165/ajrcmb.21.1.3379", "10385601"]}, {"Citation": "Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001;44(11):2653\u20132664. doi: 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1.", "ArticleIdList": ["10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1", "11710721"]}, {"Citation": "Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem. 2005;280(43):36474\u201336482. doi: 10.1074/jbc.M502851200.", "ArticleIdList": ["10.1074/jbc.M502851200", "16081426"]}, {"Citation": "Servettaz A, Guilpain P, Goulvestre C, Ch\u00e9reau C, Hercend C, Nicco C, et al. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis. 2007;66(9):1202\u20131209. doi: 10.1136/ard.2006.067504.", "ArticleIdList": ["10.1136/ard.2006.067504", "PMC1955145", "17363403"]}, {"Citation": "Goobie GC, Carlsten C, Johannson KA, Khalil N, Marcoux V, Assayag D, et al. Association of particulate matter exposure with lung function and mortality among patients with fibrotic interstitial lung disease. JAMA Intern Med. 2022 doi: 10.1001/jamainternmed.2022.4696.", "ArticleIdList": ["10.1001/jamainternmed.2022.4696", "PMC9577882", "36251286"]}, {"Citation": "Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J, Dockery D, Cohen A. Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect. 2000;108(5):419\u2013426. doi: 10.1289/ehp.00108419.", "ArticleIdList": ["10.1289/ehp.00108419", "PMC1638034", "10811568"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "5"}, {"Year": "2023", "Month": "5", "Day": "26"}, {"Year": "2023", "Month": "6", "Day": "12", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "9", "Hour": "1", "Minute": "9"}, {"Year": "2023", "Month": "6", "Day": "8", "Hour": "23", "Minute": "39"}, {"Year": "2023", "Month": "6", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["37291562", "PMC10249172", "10.1186/s12931-023-02463-w", "10.1186/s12931-023-02463-w"]}}], "PubmedBookArticle": []}